A cross-sectional survey of patients and caregivers receiving Blincyto in routine clinical practice in Europe to evaluate the effectiveness of additional risk minimisation measuresFirst published 22/02/2017 Last updated 22/02/2024 EU PAS number: EUPAS17829StudyFinalised